Why the study?
Does a single dose of cAMP phosphodiesterase inhibitor EG626 improve left ventricular function during isometric handgrip in patients with ischemic heart disease?
Does a single dose of cAMP phosphodiesterase inhibitor EG626 improve left ventricular function during isometric handgrip in patients with ischemic heart disease?
A single dose of the cAMP phosphodiesterase inhibitor EG626 may acutely improve left ventricular function and cardiac output during isometric stress in patients with ischemic heart disease.
Answers are grounded in this paper and cite their sources.
May suggest acute LV benefits during isometric stress in IHD; leaves open need for RCTs before any clinical consideration.
The effect of cAMP phosphodiesterase inhibitor EG626 on the left ventricular function was studied in 23 patients with ischemic heart disease at rest and during the IHG test. Administration of a single dose of the substance produced changes in STIs indicating an increase in cardiac output and a possible enhancement of myocardial contractility during the IHG test. EG626 may have a beneficial effect on impaired left ventricular function in patients with ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Motomiya et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: